SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000912057-02-028081
Filing Date
2002-07-22
Accepted
2002-07-22 15:22:51
Documents
2
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G a2084842zsc13g.htm SC 13G 73438
3 EXHIBIT 1 a2084842zex-1.htm EX-1 12523
  Complete submission text file 0000912057-02-028081.txt   88292
Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606
Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address 995 EAST ARQUES AVENUE SUNNYVALE CA 94085
Business Address 995 EAST ARQUES AVE SUNNYVALE CA 94085 4087740330
PHARMACYCLICS INC (Subject) CIK: 0000949699 (see all company filings)

IRS No.: 943148201 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-49440 | Film No.: 02707771
SIC: 2834 Pharmaceutical Preparations